Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tan, Lisa
1732  Ergebnisse:
Personensuche X
?
1

Management of acute breakthrough hemolysis with intensive p..:

Griffin, Morag ; Kelly, Richard J ; Panse, Jens...
Blood Advances.  8 (2024)  7 - p. 1776-1786 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Hemolysis events in the phase 3 PEGASUS study of pegcetacop..:

Peffault de Latour, Régis ; Griffin, Morag ; Kelly, Richard J....
Blood Advances.  8 (2024)  11 - p. 2718-2725 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Mixed responses to targeted therapy driven by chromosomal i..:

Hobor, Sebastijan ; Al Bakir, Maise ; Hiley, Crispin T....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Safety and Efficacy of Pegcetacoplan in Adult Patients with..:

Patriquin, Christopher J. ; Bogdanovic, Andrija ; Griffin, Morag...
Advances in Therapy.  41 (2024)  5 - p. 2050-2069 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Efficacy of adjunctive octenidine hydrochloride as compared..:

Rath, Avita ; Wong, Melissa ; Li, Keehon...
International Journal of Dental Hygiene.  , 2024
Link: https://doi.org/10.1111/..
 
?
6

Hepatic heterotopia in placenta – a case report:

Shrestha, Geetika K.C. ; Tan, Lisa
Pathology.  55 (2023)  - p. S60 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Plain Language Summary of PEGASUS, a Study Comparing Pegcet..:

Griffin, Morag ; Szer, Jeff ; Weitz, Ilene...
Future Rare Diseases.  3 (2023)  3 - p. , 2023
Link: https://doi.org/10.2217/..
 
?
8

Inhibition of C3 with pegcetacoplan results in normalizatio..:

Wong, Raymond S. M. ; Pullon, Humphrey W. H. ; Amine, Ismail...
Annals of Hematology.  101 (2022)  9 - p. 1971-1986 , 2022
Link: https://doi.org/10.1007/..
 
?
9

MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan i..:

Weitz, Ilene C. ; de Latour, Régis Peffault ; Szer, Jeffrey...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S341-S342 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Poster: MDS-134: Efficacy and Safety at 48 Weeks of Pegceta..:

Weitz, Ilene C. ; De Latour, Régis Peffault ; Szer, Jeffrey...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S228 , 2021
Link: https://doi.org/10.1016/..
 
?
11

3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLA..:

de Latour, Régis Peffault ; Szer, Jeffrey ; Weitz, Ilene...
Experimental Hematology.  100 (2021)  - p. S97 , 2021
Link: https://doi.org/10.1016/..
 
?
12

CT-286: Results of the PEGASUS Phase 3 Randomized Trial Dem..:

Castro, Carlos de ; Hillmen, Peter ; Szer, Jeff...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S216-S217 , 2020
Link: https://doi.org/10.1016/..
 
?
13

C3 inhibition with pegcetacoplan in subjects with paroxysma..:

de Castro, Carlos ; Grossi, Federico ; Weitz, Ilene Ceil...
American Journal of Hematology.  95 (2020)  11 - p. 1334-1343 , 2020
Link: https://doi.org/10.1002/..
 
?
14

A phase 1/1b study of PUR1900, an inhaled formulation of it..:

Hava, David L. ; Tan, Lisa ; Johnson, Patrick...
British Journal of Clinical Pharmacology.  86 (2020)  4 - p. 723-733 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Particle size and gastrointestinal absorption influence tio..:

Perry, Jason ; Trautman, Brian ; Takher‐Smith, Joe...
British Journal of Clinical Pharmacology.  85 (2019)  3 - p. 580-589 , 2019
Link: https://doi.org/10.1111/..
 
1-15